<i>ATM</i> germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
Sarah Elitzur(Tel Aviv University), Kjeld Schmiegelow(University of Copenhagen), Jaime Verdú‐Amorós(INCLIVA Health Research Institute), Vassilios Papadakis(Iaso Children’s Hospital), Ruth Shiloh(Tel Aviv University), Masatoshi Takagi(Tokyo Medical and Dental University), Roula Farah, Joanna Zawitkowska(Medical University of Lublin), Ifat Sarouk(Sheba Medical Center), Stefanie V. Junk(Medizinische Hochschule Hannover), Lane R. Miller(Children’s Minnesota - St. Paul Hospital), Francesco Ceppi(University of Lausanne), Gabriele Escherich(Universität Hamburg), Eftichia Stiakaki(University of Crete), Simon Bomken(Clinical Research Institute), Shai Izraeli(Tel Aviv University), Janez Jazbec, Marek Ussowicz(Wroclaw Medical University), Marion Strullu(Hôpital Robert-Debré), Oussama Abla(University of Toronto), Luca Lo Nigro(Policlinico Universitario di Catania), Nira Arad‐Cohen(Rambam Health Care Campus), Jan Starý(Charles University), Itziar Astigarraga, Jan Loeffen(Radboud University Nijmegen), Lucie Pecheux(University of Alberta), Stéphane Ducassou(Centre Hospitalier Universitaire de Bordeaux), Miriam Ben-Harosh(Soroka Medical Center), Jelena Lazić(University of Belgrade), Nizar Mahlaoui(Hôpital Necker-Enfants Malades), Thai Hoa Tran(University of California, San Francisco), Nicole Bodmer(University Children's Hospital Zurich), Véronique Minard‐Colin(Inserm), Sarah K. Tasian(Children's Hospital of Philadelphia), Triantafyllia Brozou(Heinrich Heine University Düsseldorf), Henrik Hasle(Aarhus University Hospital), Dominique Stoppa‐Lyonnet(Centre National de la Recherche Scientifique), Alexandra Kolenová(Comenius University Bratislava), Marta Pillon(University of Padua), Anna Wakulińska(Children's Memorial Health Institute), Amber Gibson(The University of Texas MD Anderson Cancer Center), Yosef Shiloh(Tel Aviv University), Julieta Hoveyan, Elad Jacoby(Edmond and Lily Safra Children's Hospital), A. Malcolm R. Taylor(Cancer Research UK Clinical Trials Unit), André Baruchel(Hôpital Robert-Debré), Liliia Chugaeva(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Agata Pastorczak(Medical University of Lodz), Luciano Dalla Pozza(ANZCHOG), Thomas Lehrnbecher(Goethe University Frankfurt)
Cited by 24
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k